Press Releases

Date Title and Summary View
Toggle Summary MediWound Prices Initial Public Offering View HTML
Toggle Summary Positive Recommendation for Marketing Authorization from the European Medicines Agency for its innovative drug – NexoBrid™
NexoBrid™ has shown statistically significant effect in earlier eschar removal from burn wounds and reduction in the number and extent of surgical excision and autografting